Berkeley, CA -- (SBWIRE) -- 06/26/2013 -- Diindolylmethane (DIM) News Update from the Diindolylmethane (DIM) Information Resource Center, UC Berkeley (http://www.diindolylmethane.org/)

Resveratrol from grapes has received a lot of coverage in the press as an anti-aging molecule for potentiating molecular processes that slow down the aging process and promoting life extension. A compound in broccoli, however, called Diindolylmethane (DIM), formed during the digestion of this vegetable, has recently been found to potentiate similar molecular pathways that slow down the aging process and promote life extension.

The paper was recently published in the March edition of Aging Cell and has taken some time to be digested by the scientific community. As the media and science writers covering recent developments in the field of nutrition slowly begin to notice and digest the findings of this paper published by German scientists at the Duisburg-Essen University in Germany, we thought this would be an outstanding opportunity to provide a brief overview of this important compound from Broccoli so that science writers within the media community and members of the general public get a better appreciation for recent developments regarding this very important naturally occurring molecule found in broccoli.

When science writers in the media write about the health benefits of broccoli, they often focus solely on Sulforaphane, which at Johns Hopkins has been found to promote cellular detoxification. Sulforaphane has long had an important cousin, called Diindolylmethane, which has not received as much attention in the press, but from a point of view of therapeutic potential, it arguably has significantly higher potential.

An overview of how Diindolylmethane is formed during the digestive process and its molecular biology as well as scientific references dating back to 1975 are available at the Diindolylmethane (DIM) Information Resource Center at UC Berkeley (http://www.diindolylmethane.org/)

Diindolylmethane from broccoli has numerous very favorable biologic activities which are the basis for why the National Cancer Institute has launched numerous clinical trials to study its potential as a therapeutic for multiple forms of cancer.

Among these biologic activities, the most important are:

1) Anti-inflammatory properties through the down regulation of NFK-B, a well-known inflammatory drug target with therapeutic properties for both cancer and cardiovascular disease.
2) Immune Activation through the induction of Interferon-Gamma Receptors and Interferon-Gamma itself which are well understood in the scientific community for their antiviral, antibacterial and anticancer properties.
3) Synergy with Interferon-Gamma in the induction of the MHC-I complex which helps to flag cancer and infectious disease antigens to the immune system for destruction.
4) The promotion of apoptosis through inhibition of PI3K /Akt. Apoptosis is programmed cell death. Normal cells have this process as a part of their life cycle but cancer cells lose this ability in the process of becoming cancerous. Hence it is an important mechanism by which cancer cells can be promoted to destroy themselves—behaving like normal cells again.
5) Promotion of P38 and P21 which promote cytostasis of cancerous cells.

When all of the above are taken into account some of the epidemiological studies regarding Brassica vegetable consumption and a lower risk of cancer come to light.

In 2001, a study published in the Journal of the American Medical Association discussed how women who consume just one serving of Brassica vegetables per week exhibit a 40% reduction in the risk of breast cancer development relative to those who consume very little of this vegetable group in their diet. In 2007, scientists at the National Cancer Institute published their finding that men who consume just one serving of Cruciferous (Brassica) vegetables per week reduce their risk of developing aggressive prostate cancer by up to 52%. Interestingly enough, in this study, no other vegetable group appeared to provide a statistically significant risk reduction for prostate cancer.

In a seminal paper published in 2006, Diindolylmethane was shown to synergize with Taxol (best-selling cancer drug worldwide that also originated from plants). In this paper the authors demonstrate how DIM significantly enhances the efficacy of this important and widely used cancer drug.

In another important paper that came out in the January of 2013, Scientists at the Karamos Cancer Institute published that Diindolylmethane (DIM) enhances the effectiveness of Herceptin--leading therapeutic for breast cancer currently marketed by biotech giant Genentech.

And now from this recent study in Germany, we can add to Diindolylmethane's multitude of favorable biological properties, the slowing down of the aging process and life extension.

Indeed Brassica vegetables (broccoli, cauliflower, cabbage, brussels sprouts) are among the most important from a preventive nutrition point of view in the human diet given the number of extremely favorable and health-promoting activities of Diindolylmethane (DIM).

Based on a breakthrough discovery regarding Diindolylmethane's immune activating properties, a dietary supplement called ActivaMune has been launched with technology exclusively licensed from UC Berkeley that has DIM in it along with other important nutrients. The product is a fund-raiser for nature-based cancer research and it provides the phytonutrient equivalent of consuming five pounds of fresh organic broccoli per day. More information about ActivaMune can be found at http://www.activamune.com/.

From all of us at the Diindolylmethane (DIM) Information Resource Center to you, we wish you and your family health, longevity and good nutrition for years to come.

Regards,

Diindolylmethane (DIM) Information Resource Center News Team

http://www.diindolylmethane.org

References:

Aging Cell. 2013 Mar 23. Chemical genetic screen in fission yeast reveals roles for vacuolar acidification, mitochondrial fission, and cellular GMP levels in lifespan extension. Stephan J, Franke J, Ehrenhofer-Murray AE. Zentrum fuer Medizinische Biotechnologie, Universitaet Duisburg-Essen, Essen, Germany.

Brassica Vegetables and Breast Cancer Risk. Terry P, Wolk A, Persson I, Magnusson C, JAMA 2001 285 (23): 2975-2976

Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer. Journal of the National Cancer Institute. 2007 Jul 24; Krish VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB

3,3'-diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells. PLoS One. 2013;8(1):e54657. Epub 2013 Jan 22. Ahmad A, Ali S, Ahmed A, Ali AS, Raz A, Sakr WA, Rahman KW. Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, United States of America.

3,3-Diindolylmethane and Paclitaxel Act Synergistically to Promote Apoptosis in HER2/Neu Human Breast Cancer Cells. Journal of Surgical Research, 2006 May 15;132(2):208-13. K. McGuire, N. Ngoubilly, M. Neavyn, S. Lanza-Jacoby Department of Surgery, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107

Scientific Information about Diindolylmethane's Immune Activation Properties can be found at the Diindolylmethane (DIM) Immune Activation Data Center: www.activamune.com/diindolylmethane_dim_immune_activation_data_center.htm

In-Depth Scientific Information and References on Diindolylmethane dating back to 1975 can be found at the UC Berkeley Diindolylmethane (DIM) Information Resource Center: www.diindolylmethane.org

More information about ActivaMune, natural immune booster and a fundraiser for nature-based cancer research, is available at: www.activamune.com

Contact:
Diindolylmethane (DIM) Information Resource Center News Team
www.diindolylmethane.org
2887 College Ave. #351
Berkeley, CA 94705

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Talking about this scientific breakthrough at Berkeley, Clinical Immunologist Dr. Janet Baum stated, “This is one of the most profound discoveries in the field of immunology.

Berkeley, CA -- (SBWIRE) -- 06/26/2013 -- Berkeley BioSciences, Inc. has launched a new formulation of natural immune system booster, ActivaMune based on a breakthrough discovery by the Chairman of the Nutritional Sciences Department and the NIH Director of Cancer Research at UC Berkeley regarding the compound Diindolylmethane (DIM) from broccoli which has been discovered to potently activate the immune system. This natural immune booster enhances the immune system and supports multiple organs throughout the body. The new formulation consists of: 800 mg ActivaMune DIM Complex, 800 IU Vitamin D3, 60 mg Vitamin C, 30 IU Vitamin E, 50 mg Calcium, 50 mcg Selenium, 6mg Lutein, 6mg Lycopene, 500 mcg Zeaxanthin and 300 mcg Sulforaphane.

Talking about this scientific breakthrough at Berkeley, Clinical Immunologist Dr. Janet Baum stated, "This is one of the most profound discoveries in the field of immunology. Its implications are so far reaching that it is worthy of a Nobel Prize nomination. One cannot review the data without experiencing a eureka moment."

This Diindolylmethane DIM supplement is a product that works best when taken on a regular basis as a part of one's nutritional wellness regimen. A bottle of ActivaMune has 60 vegetarian capsules. Consumers are advised to take 2 capsules a day. By joining the US and International Quarterly Program, customers can get three bottles of ActivaMune sent to them every three months with free shipping worldwide.

ActivaMune is a patented formula exclusively marketed by Berkeley BioSciences, Inc. under license from the University of California at Berkeley.

About Berkeley BioSciences Inc.
Berkeley BioSciences Inc. is dedicated to helping people lead healthier lives through the development of first-in-class nutrition and healthcare products based on rigorous scientific research and proprietary knowledge. The company has two divisions: Nutraceutical and Biopharmaceutical. The Nutraceutical Division markets ActivaMune and the Biopharmaceutical Division is researching and developing nature-based therapeutics for multiple forms of cancer (breast, prostate, lung, colon and cervical) and infectious diseases like AIDS, SARS, Hepatitis, HPV, Influenza, Pandemic Flu.

For more information, please visit http://www.activamune.com

Contact Detail:
ActivaMune Health Supplement
Customer Service Mail Center
1434 Westwood Blvd. # 5
Los Angeles, CA 90024
Customer Service Telephone: US Toll-Free 1-877-777-0719

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm